PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |cirrhosis |
| Sentences | 144 |
| PubMedID- 23047000 | Background: in the western world, hepatocellular carcinoma seldom develops in patients without cirrhosis, and reports describing the characteristics of non-cirrhotic patients with hepatocellular carcinoma are rather infrequent. |
| PubMedID- 25459558 | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. |
| PubMedID- 22099524 | Aim: to assess whether t2-weighted imaging (t2wi) provides any added value for the detection of hepatocellular carcinoma (hcc) in patients with cirrhosis, especially for lesions smaller than 2 cm. |
| PubMedID- 25714713 | Finally, the higher induction of egr1 related to genotype 3a is of interest in that it has been identified recently as a molecular marker for the development of hepatocellular carcinoma in patients with hcv-related cirrhosis (19); moreover, ipa predicted inhibition of mirna-154 and mirna-25, both recently linked with suppression of cancer cell growth (39–41). |
| PubMedID- 21991498 | A 67-year-old woman with compensated cirrhosis type b associated with hepatocellular carcinoma was started on sorafenib for multiple pulmonary metastases. |
| PubMedID- 22869451 | In this issue of the journal (beginning on page 1007), nkontchou and colleagues report their retrospective observational finding that the beta-blocker propranolol was associated with a highly statistically significant reduction in the incidence of hepatocellular carcinoma in patients with advanced cirrhosis and related esophageal varices. |
| PubMedID- 24932302 | Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: a report of two cases. |
| PubMedID- 24893685 | Background: an association between transjugular intrahepatic porto-systemic shunt (tips) and the development of hepatocellular carcinoma in patients with cirrhosis has been suggested, but not confirmed. |
| PubMedID- 21457561 | An estimated 3% of the world's population is chronically infected with hepatitis c virus (hcv) which is the main cause of liver fibrosis and cirrhosis, often leading to hcc (hepatocellular carcinoma) in a substantial number of patients. |
| PubMedID- 25427740 | Background: in most guidelines, no other interventional therapy but liver transplantation is recommended for the treatment of hepatocellular carcinoma (hcc) with child-pugh c cirrhosis (cp-c). |
| PubMedID- 22537432 | Most cases of hepatocellular carcinoma (hcc) are associated with cirrhosis related to chronic hepatitis b virus (hbv) or hepatitis c virus (hcv) infection. |
| PubMedID- 23710205 | Mostly chronic hepatitis c virus has a uniform natural history, from liver cirrhosis to the development of hepatocellular carcinoma. |
| PubMedID- 26431433 | Persistent infection with hbv can cause severe liver injury, cirrhosis, and the development of hepatocellular carcinoma (hcc) 1. |
| PubMedID- 21188198 | Chronic hepatitis c is a major cause of chronic liver disease globally, and the natural history of progression may lead to cirrhosis with liver failure, hepatocellular carcinoma, and premature liver-related death. |
| PubMedID- 24564496 | To demonstrate its utility, we applied rmani to a hepatocellular microarray dataset containing normal tissue and three disease conditions: pre-malignant (cirrhosis), cirrhosis with hepatocellular carcinoma (cirrhosishcc), and hepatocellular tumor (hcc). |
| PubMedID- 21462175 | Resection of hepatocellular carcinoma in patients without cirrhosis (br j surg 2011; 98: 697-703). |
| PubMedID- 25339803 | Some of these people will develop hepatic cirrhosis with decompensation and/or hepatocellular carcinoma. |
| PubMedID- 22363353 | Some individuals with persistent hcv infections develop liver cirrhosis, which can lead to hepatocellular carcinoma in some patients . |
| PubMedID- 26469163 | Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively. |
| PubMedID- 24352343 | There were 383 patients with cirrhosis associated with hepatocellular carcinoma (hcc). |
| PubMedID- 25969676 | Two more cases with smh were reported, however one had hepatocellular carcinoma as the cause of cirrhosis and the other one had alpha-1 antitrypsin deficiency as the cause of cirrhosis. |
| PubMedID- 26404355 | The second option is to achieve on treatment undetectable hcv rna at lt. in a recent study, aimed to prevent hcv recurrence on the graft, sof plus rbv was used in 61 lt candidates (genotype 1: 74%, previously treated: 75%, median model for end-stage liver disease (meld) score = 8; 6 to 14) listed for compensated cirrhosis with hepatocellular carcinoma, until the time of lt or for up to 48 weeks . |
| PubMedID- 26273598 | Simple steatosis, or fatty liver, occurs early in nafld and may progress to nonalcoholic steatohepatitis (nash), fibrosis, and cirrhosis with increased risk of hepatocellular carcinoma . |
| PubMedID- 21247464 | An estimated 3% of the world's population (270 million people) is chronically infected by hcv which is the main cause of liver fibrosis and cirrhosis that leads to hepatocellular carcinoma (hcc) in a significant number of patients . |
| PubMedID- 20425481 | Progressive hepatic fibrosis is the final common pathway for most chronic liver injuries, leading to cirrhosis with risk of liver failure and hepatocellular carcinoma. |
| PubMedID- 20004441 | Background: the choice between minor versus major resection or anatomic versus nonantatomic resection for small (<5 cm) solitary hepatocellular carcinoma (hcc) in patients with cirrhosis is controversial. |
| PubMedID- 23825904 | Material and methods: thirty-five cases each of chronic hcv hepatitis type 4 (group i) and cirrhosis with hepatocellular carcinoma (hcc) complicating chronic hcv hepatitis (groups ii and iii) were immunohistochemically evaluated using a p21 ras polyclonal antibody. |
| PubMedID- 23780836 | Conclusion: serum endocan and syndecan-1 are easily assessable prognostic serum biomarkers of overall survival in alcoholic cirrhosis with and without hepatocellular carcinoma. |
| PubMedID- 21689619 | While initially performed only for benign hepatic lesions, the indications for laparoscopic resection have gradually broadened to encompass all kinds of malignant hepatic lesions, including hepatocellular carcinoma in patients with cirrhosis, for whom the advantages of the minimally invasive approach may be most evident. |
| PubMedID- 21302626 | Effective and safe systemic treatment for advanced hepatocellular carcinoma (hcc) with severe underlying cirrhosis is not yet available. |
| PubMedID- 20845516 | Aim: to determine the role of diabetes mellitus (dm) and other associated factors in chinese hepatocellular carcinoma (hcc) patients with cirrhosis, compared with those hcc patients without cirrhosis, in the single setting of hepatitis b virus (hbv) infection, after other known concomitant diseases were excluded. |
| PubMedID- 25630422 | Laparoscopic radiofrequency ablation should be considered a safe treatment for hepatocellular carcinoma patients with severe cirrhosis and impaired icg-15 test. |
| PubMedID- 22038662 | Results: fifteen hepatocellular carcinoma patients with child-pugh a cirrhosis, in whom sorafenib dosing remained unchanged from initiation of treatment to disease progression, were eligible for this analysis. |
| PubMedID- 21357524 | Purpose: to investigate the usefulness of computed tomographic (ct) spectral imaging parameters in differentiating small (hepatocellular carcinoma (hcc), with or without cirrhosis, during the late arterial phase (ap) and portal venous phase (pvp). |
| PubMedID- 20517476 | Hepatitis c virus (hcv) is a major human health problem worldwide which can result in acute and chronic hepatitis, cirrhosis, and/or development of hepatocellular carcinoma. |
| PubMedID- 21331263 | Patients can evolve from chronic hepatitis directly to hepatocellular carcinoma without first developing cirrhosis, especially those with genotype 1b 5. |
| PubMedID- 24559750 | Mri of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (cirrhosis and chronic viral hepatitis: a comparative study. |
| PubMedID- 24020023 | Indications for living-donor liver transplantation in these patients were hepatitis b cirrhosis with hepatocellular carcinoma (n = 8), hepatitis b cirrhosis without hepatocellular carcinoma (n = 3), autoimmune disease (n = 1), and wilson's disease (n = 2). |
| PubMedID- 23113141 | Self-limited acute or fulminant hepatitis, asymptomatic infection, or chronic hepatitis with progression to liver cirrhosis that can lead to hepatocellular carcinoma (10). |
| PubMedID- 20001440 | Background: squamous cell carcinoma antigen-immunoglobulin m (scca-igm) is a useful biomarker for the risk of development of hepatocellular carcinoma (hcc) in patients with cirrhosis due to its progressive increase associated to hcc evolution. |
| PubMedID- 25473157 | These include those with underlying cirrhosis, severe flares of chb, hepatocellular carcinoma (hcc), and for those undergoing liver transplantation. |
| PubMedID- 22056847 | Hepatitis b virus (hbv) infection has a wide variety of clinical outcomes, it could be spontaneouly recovered and also could develop fulminant liver failure or cirrhosis with hepatocellular carcinoma. |
| PubMedID- 24940392 | The prevalence of cirrhosis in patients with hepatocellular carcinoma (ht) is between 80 and 90%, while 10–20% of ht cases develop in patients without cirrhosis (7). |
| PubMedID- 23530966 | Results: more than half of the patients had cirrhosis with hepatocellular carcinoma. |